Non-invasive Neurostimulation in Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Parkinson's Disease
Interventions
PROCEDURE

low-intensity transcranial electrical stimulation

Subjects will undergo 20 minutes of low-intensity transcranial electrical stimulation of up to 2mA. During active stimulation, the current will be active for 20 minutes - however, during sham stimulation (placebo) the current will not be active for the full 20 minutes.

PROCEDURE

transcranial ultrasound

Subjects will undergo 20 minutes of transcranial ultrasound. During active stimulation, the ultrasound will be active for 20 minutes - however, during sham stimulation (placebo) the ultrasound will not be active for the full 20 minutes.

Trial Locations (1)

02144

Spaulding Rehabilitation Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Highland Instruments, Inc.

INDUSTRY

lead

Spaulding Rehabilitation Hospital

OTHER

NCT01615718 - Non-invasive Neurostimulation in Parkinson's Disease | Biotech Hunter | Biotech Hunter